- Childhood cancers
- Colon cancer
- Gastrointestinal Carcinoid Tumor
- Small Intestine
- Head and Neck
- HIV and AIDS Related
- Kaposi Sarcoma
- Multiple Myeloma
- Metastatic Cancer
- Recurring Cancers
- Secondary (Metastatic)
- Squamous Cell
- Adjuvant Chemotherapy
- Biological Therapy
- Cesium Chloride
- Docetaxel (Taxotere)
- Doxorubicin (Adriamycin)
- Oral Chemotherapy
- Paclitaxel (Taxol)
- Pixantrone (Pixurvi)
- Platinum-based chemotherapy
- Chemotherapy Regimens
- Clinical Trials
- Gene Therapy
- Gerson Therapy
- Hormone Therapy
- Laser Therapy
- Platinum-based Therapy
- Targeted Therapies
- Pain Management
- Proton Therapy
- Watchful Waiting
Etoposide cancer treatment
Etoposide is a commonly-used chemotherapy drug derived from the toxin podophyllotoxin, found in Podophyllum peltatum, also known as the Mayapple, a North American plant. Etoposide has been in use as an anticancer agent for nearly three decades.
- Class: Topoisomerase II inhibitor
- Mechanism of action: Etoposide inhibits a specific enzyme in the cell that unravels DNA, causing the strands to break and leading to cell death.
- Treatment type: Chemotherapy
- US approval: 1983
- Synonyms: VePesid, Toposar, VP-16
- FDA Use-in-Pregnancy Rating: Category D
What Etoposide is effective for and why
Etoposide has many anti-cancer applications. It has been used to treat germ cell tumors, small cell lung cancer, non-small cell lung cancer, acute myeloid leukemia, testicular cancer, Hodgkin lymphoma, non-Hodgkin lymphomas, adrenocortical cancer, carcinoid tumors, brain cancer, breast cancer, and ovarian cancer. Etoposide is featured in several combination chemotherapy regimens, chiefly for the lymphomas. These include CBV, CEP, I-VAC, BEAM, Dexa-BEAM, Mini-BEAM, Stanford V, BEACOPP, CEVD, CAPE/PALE, EPOCH, ESHAP, ICE and R-ICE.
Etoposide is a commonly used component of preparative salvage regimens given to patients prior to undergoing bone marrow transplantation.
Etoposide side effects: Overview
While each patient will have his or her own experiences with the side effects of etoposide, most patients will likely experience myelosuppression (leukopenia), and those receiving oral etoposide are more prone to experience nausea and/or vomiting than those receiving the drug by IV. Otherwise, patients may endure flu symptoms, loss of appetite, increased heart rate, fatigue, skin rash, and possibly some hair loss. Most if not all of these side effects should subside when one is finished with receiving etoposide. Patients are encouraged to report all side effects to their oncologist or oncology team.
- Boyiadzis, Michael M. et al. Hematology-Oncology Therapy. 2007. New York: McGraw Hill, Medical Publishing Division.
- Guide to Cancer Drugs, American Cancer Society
- Cancer Drug Manual, BC Cancer Agency
- Perry, Michael C, Editor. Companion Handbook to the Chemotherapy Sourcebook. 1999. Baltimore; Williams & Wilkins.
- Drugs.com: Etoposide
Significant studies relating to etoposide
- Felix W, Senn HJ. "Clinical study of the new podophyllotoxin derivative, 4'-demethylepipodophyllotoxin 9-(4,6-o-ethylidene- beta-D-glucopyranoside) (NSC-141540; VP-16-213), in solid tumors." Cancer Chemother Rep. 1975 Jul-Aug;59(4):737-42.
- Turrisi AT et al. "Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide." N Engl J Med 1999 Jan 28;340(4):265-71.
- Moskowitz CH et al. "Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma." J Clin Oncol 1999 Dec;17(12):3776-85.
The information provided on CancerTreatment.net is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational purposes and does not constitute the practice of medicine. We encourage all visitors to see a licensed physician or nutritionist if they have any concerns regarding health issues related to diet, personal image and any other topics discussed on this site. Neither the owners or employees of CancerTreatment.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.